Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Repligen Q4 Adjusted EPS USD 0.33 Vs. IBES Estimate USD 0.33

Feb 21 (Reuters) - Repligen Q4 adjusted net income USD 18.8 million.
* Q4 adjusted operating income USD 18.8 million
* Q4 revenue USD 156 million vs. IBES estimate USD 155.4 million

Recent news on Repligen

See all news